Detalles de la búsqueda
1.
Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancer.
Invest New Drugs
; 37(3): 482-489, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30302599
2.
A pilot study of JI-101, an inhibitor of VEGFR-2, PDGFR-ß, and EphB4 receptors, in combination with everolimus and as a single agent in an ovarian cancer expansion cohort.
Invest New Drugs
; 33(6): 1217-24, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26365907
3.
A Phase III study of radiation therapy (RT) and O6-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001.
Int J Clin Oncol
; 20(4): 650-8, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25407559
4.
Discriminate gene lists derived from cDNA microarray profiles of limited samples permit distinguishing mesenchymal neoplasia ex vivo.
J Cancer Res Clin Oncol
; 131(3): 137-46, 2005 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15614524
5.
Design, Synthesis and Biological Evaluation of a Series of Novel Axl Kinase Inhibitors.
ACS Med Chem Lett
; 2(12): 907-912, 2011 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-22247788
Resultados
1 -
5
de 5
1
Próxima >
>>